Characteristics (mean ± SD) RA patients (40) Control (30) p value
Age (years) 46.95 ± 11.60 43.7 ± 9.9 0.542
Sex (F/M) 26/14 18/12 0.532
Disease duration (years) 4.57 ± 2.59 -  
Morning stiffness (min) 18.84 ± 9.04 -  
VAS (0–10) 4.62 ± 1.40 -  
Number of swollen joints 2.32 ± 1.18 -  
Number of tender joints 3.89 ± 2.08 -  
DAS28 score 3.79 ± 0.66 -  
HAQ score 11.49 ± 4.15 -  
ESR (mm/1st hr) 42.65 ± 8.59 -  
Rheumatoid factor (%) 46.0 ± 9.8 -  
CRP (mg/l) 18.65 ± 9.59 -  
Body mass index (BMI) 14.15 ± 11.48 27.85 ± 2.62  
Anti-CCP2 (U/ml) 89.2 ± 11.3 14.8±3.21 <0.001**
Anti-MCV (U/ml) 114.45 ± 16.57 9.05 ± 3.67 <0.001**
RF: Rheumatoid Factor; MS: Morning Stiffness; VAS: Visual Analog Scale of pain; DAS28: Disease activity for 28 joint indices score; HAQ: Health Assessment Questionnaire; ESR: Erythrocyte Sedimentation Rate; CRP: C-Reactive Protein; BMI: Body Mass Index; Anti-CCP2: Antibodies against Cyclic Citrullinated Peptide2; Anti-MCV: Antibodies against Mutated Citrullinated Vimentin ** Highly significant
Table 1: Demographic and clinical characteristics of rheumatoid arthritis (RA) patients and control.